Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)

被引:0
|
作者
Salud, A.
Escudero, P.
Feliu, J.
Lopez-Gomez, L.
Bolanos, M.
Galan, A.
Yubero, A.
Vicent, J. M.
Losa, F.
Gonzalez-Baron, M.
机构
[1] Hosp Arnau Vilanova, Med Oncol Serv, Lleida, Spain
[2] Hosp Lozano Blesa, Med Oncol Serv, Zaragoza, Spain
[3] Hosp La Paz, Med Oncol Serv, Madrid, Spain
[4] Hosp Virgen Salud, Med Oncol Serv, Toledo, Spain
[5] Hosp San Pedro Alcantara, Med Oncol Serv, Caceres, Spain
[6] Hosp Sagunto, Med Oncol Serv, Valencia, Spain
[7] Hosp Obispo Polanco, Med Oncol Serv, Teruel, Spain
[8] Hosp Gen Univ, Med Oncol Serv, Valencia, Spain
[9] Hosp Creu Roja De Barcelona, Med Oncol Serv, Barcelona, Spain
来源
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:190 / 190
页数:1
相关论文
共 50 条
  • [1] XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC).
    López-Gómez, L
    Escudero, P
    Yubero, A
    Feliú, J
    Salud, A
    Galán, A
    Bolaños, M
    Vicent, JM
    Losa, F
    González-Barón, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 291S - 291S
  • [2] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [3] Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
    Grande, Carlos
    Quintero, Guillermo
    Candamio, Sonia
    Paris Bouzas, Lorena
    Jose Villanueva, Maria
    Campos, Begona
    Gallardo, Elena
    Alvarez, Elena
    Casal, Joaquin
    Ramon Mel, Jose
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (02) : 114 - 121
  • [4] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [5] XELOX (capecitabine and axaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC).
    Salud, A
    Escudero, P
    Feliú, J
    López-Gómez, L
    Bolanos, M
    Galán, A
    Yubero, A
    Vicent, JM
    Losa, F
    Barón, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 276S - 276S
  • [6] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (Pts) with metastatic colorectal cancer (MCRC)
    Laudani, A.
    Savio, G.
    Leonardi, V.
    Palmisano, V.
    Tartaglia, L.
    Manuguerra, G.
    Pepe, A.
    Alu, M.
    Usset, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 6 - 6
  • [7] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (PTS) with metastatic colorectal cancer (MCRC)
    Laudani, Agata
    Savio, Giuseppina
    Leonardi, Vita
    Palmisano, Valentina
    Rondello, Giacomo
    Alu, Massimiliano
    Pepe, Alessio
    Calabria, Caterina
    Usset, Antonella
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2006, 17 : 119 - 119
  • [8] XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
    J Feliu
    A Salud
    P Escudero
    L Lopez-Gómez
    M Bolaños
    A Galán
    J-M Vicent
    A Yubero
    F Losa
    J De Castro
    M Á de Mon
    E Casado
    M González-Barón
    British Journal of Cancer, 2006, 94 : 969 - 975
  • [9] XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
    Feliu, J
    Salud, A
    Escudero, P
    Lopez-Gómez, L
    Bolaños, M
    Galán, A
    Vicent, JM
    Yubero, A
    Losa, F
    De Castro, J
    de Mon, MA
    Casado, E
    González-Barón, M
    Oncopaz Cooperative Grp
    BRITISH JOURNAL OF CANCER, 2006, 94 (07) : 969 - 975
  • [10] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091